Austin Speier

Austin Speier serves as the Chief Strategy Officer, bringing extensive experience from his previous role as Vice President, Emerging Technologies at Precision for Medicine. In his career, he has advised on the design and execution of development and go-to-market strategies for complex or first-in-class products. Speier has worked closely with early-stage and venture-backed clients to address critical scientific, clinical, regulatory, and reimbursement issues. His research experience includes conducting studies at the Brigham & Women’s Hospital Center for Neurodegeneration and Disease, focusing on Alzheimer’s Disease. Speier holds an A.B. cum laude in Biology from Harvard College and completed the interdisciplinary Honors Neurobiology program, receiving a certificate in Mind, Brain, and Behavior Studies.